Violation Tracker Individual Record

Company: 
Cephalon, Inc.
Current Parent Company: 
Teva Pharmaceutical Industries
Penalty: 
$1,200,000,000
Year: 
2015
Date: 
May 28, 2015
Primary Offense: 
consumer protection violation
Secondary Offense: 
price-fixing or anti-competitive practices
Violation Description: 

The Federal Trade Commission reached a settlement resolving a suit accusing Cephalon, Inc. of illegally blocking generic competition to its blockbuster sleep-disorder drug Provigil. The settlement ensures that Teva Pharmaceutical Industries, Ltd., which acquired Cephalon in 2012, will make a total of $1.2 billion available to compensate purchasers, including drug wholesalers, pharmacies, and insurers, who overpaid because of Cephalon's illegal conduct.

Level of Government: 
federal
Action Type: 
agency action
Agency: 
Federal Trade Commission
Civil or Criminal Case: 
civil
HQ Country of Parent: 
Israel
Ownership Structure of Parent: 
publicly traded
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.